Gonadorelin (GnRH)

Gonadorelin is a synthetic pharmaceutical form of Gonadotropin-Releasing Hormone (GnRH), a decapeptide that is naturally produced in the hypothalamus. Gonadorelin is structurally identical to endogenous GnRH and serves as the primary regulator of the reproductive endocrine system.

Its mechanism of action involves binding to GnRH receptors on the anterior pituitary gland. This binding stimulates the synthesis and secretion of the two essential gonadotropins: Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). These hormones, in turn, act on the gonads (testes and ovaries) to regulate sex hormone production (testosterone and estrogen) and gametogenesis (sperm and egg development).

The physiological effect of Gonadorelin is critically dependent on its pattern of administration. When delivered in a pulsatile fashion that mimics the body's natural rhythm, it is stimulatory. However, when administered continuously, it leads to the downregulation and desensitization of pituitary GnRH receptors, paradoxically suppressing LH and FSH release and shutting down gonadal hormone production. Due to its very short half-life, it is primarily used clinically as a diagnostic agent to test pituitary function or for pulsatile therapies.